Three more updates to protect your gains

DUN & BRADSTREET HOLDINGS INC. $14 remains a buy. The company (New York symbol DNB; Aggressive Growth Portfolio, Finance sector; Shares outstanding: 433.8 million; Market cap: $6.1 billion; Price-to-sales ratio: 2.7; Dividend yield: 1.4%; TSINetwork Rating: Extra Risk; www.dnb.com) continues to benefit from its January 2021 acquisition of… Read More

These ETFs profit from steady demand

Traditionally, the price of most stocks, and the ETFs that hold them, drop during bear markets like the one we saw in 2022. However, certain segments generally perform better than the overall market during downturns—and bounce back faster, including during the 2000-2002 and 2008-2009 bear… Read More

Former parent is the better pick

Merck—like other big pharmaceutical makers Pfizer and Johnson & Johnson—recently spun off some of its legacy businesses. Merck’s split came in June 2021 with the creation of Organon & Co. Investors received one share in the new firm for every 10 Merck shares they held.
Since… Read More

Pfizer to boost COVID vaccine prices

PFIZER INC. $46 is a buy. The company (New York symbol PFE; Income-Growth Dividend Payer Portfolio, Manufacturing sector; Shares outstanding: 5.6 billion; Market cap: $257.6 billion; Dividend yield: 3.5%; Dividend Sustainability Rating: Highest; www.pfizer.com) is one of the world’s largest makers of prescription drugs. Its top-selling brands include Eliquis… Read More